July 2023 in “Dermatology Practical & Conceptual” This study found that a positive anagen pull test can be an indicator of lichen planopilaris activity, suggesting its utility in the clinical assessment of this condition.
December 2023 in “Minia Journal of Medical Research” In this study, researchers found that transverse sections of alopecia areata lesions showed significantly more terminal hair follicles with perifollicular lymphocytic infiltrate compared to longitudinal sections, and this immune infiltration positively correlated with the positive hair pull test in patients.
July 2021 in “Australasian Journal of Dermatology” This manuscript describes a proposed ‘trichoscopy-assisted hair pull test’ that enhances the diagnosis of hair loss conditions by allowing immediate examination of proximal hair shafts and roots in patients with a positive hair pull test.
10 citations
,
August 2011 in “Clinics” This article presents a dissenting opinion, arguing that the case described by Dr. Molina et al. was diffuse alopecia areata, not acute alopecia areata as claimed, emphasizing the importance of distinct clinical differences.
1 citations
,
December 2022 in “Journal of cosmetic dermatology” This study found that combining a potent steroid with a vitamin D analogue may offer more convenient treatment for localized alopecia areata than using a superpotent steroid alone, with comparable efficacy but fewer side effects.
May 2023 in “Journal of contemporary medicine” This study observed that patients who received Favipiravir treatment after having COVID-19 had lower positive pull test scores for telogen effluvium hair loss compared to those who did not, suggesting that Favipiravir may not influence the development of telogen effluvium.
35 citations
,
January 1993 in “International Journal of Dermatology” In this study, most hair disorders among HIV-1 positive patients were associated with low helper T cell counts, with papulosquamous conditions like seborrheic dermatitis and psoriasis being the most common.
August 2021 in “Zenodo (CERN European Organization for Nuclear Research)” This study observed that while platelet-rich plasma showed positive short-term effects on hair density in individuals with androgenic alopecia, its effectiveness declined after four months, suggesting possible need for additional treatment.
4 citations
,
January 2015 in “Annals of Dermatology” This report describes a case of temporary hair loss due to telogen effluvium after rhytidectomy, suggesting dermatologic surgeons consider preventive measures to minimize trauma and tension on hair follicles during surgery.
60 citations
,
October 2009 in “PubMed” This study reports that intralesional triamcinolone acetonide was effective and well-tolerated for treating extensive alopecia areata in patients who often showed specific initial hair characteristics.
In this observational study, researchers found that acute telogen effluvium, a form of temporary hair loss, occurred in 80 patients following COVID-19 infection, with 70 showing a significant decrease in hair density and trichoscopic signs like peripilar sign and yellow dots.
9 citations
,
January 2006 in “American Journal of Clinical Dermatology” This study found that Malassezia carriage was significantly more common among participants experiencing hair shedding, suggesting a potential link between this fungal presence and hair loss.
6 citations
,
October 2012 in “BMJ” This case report describes a 37-year-old woman whose recurrent hair shedding was associated with low iron stores and a miscarriage, with improvements seen after increased iron intake.
4 citations
,
February 2022 in “Journal of Cosmetic Dermatology” This study found that patients with telogen effluvium had a higher rate of acute hair loss and lower monocyte counts if they had contracted COVID-19 prior to hair loss onset.
3 citations
,
April 2021 in “Berkala ilmu kedokteran/Journal of the medical sciences” This report describes a case of tinea capitis caused by Epidermophyton floccosum, highlighting its unusual ability to perforate hair and act as an etiological agent for the condition.
2 citations
,
January 2022 in “Journal of Cosmetic Dermatology” This study found that intradermal administration of QR678 Neo® significantly reduced hair fall and improved hair growth in patients with androgenetic alopecia and female pattern hair loss, with no side effects reported during long-term follow-up.
2 citations
,
June 2017 in “Pediatric Dermatology” This case report describes a 2-year-old boy in critical condition who developed anagen effluvium, possibly due to hypotension and hypoxia triggering hair follicle apoptosis.
1 citations
,
December 2015 in “TURKDERM” This study found that treatment improved symptoms and stopped disease progression for 75% of lichen planopilaris patients whose follow-up data were available.
January 2026 in “International Journal of Dermatology Research” This case report discusses a young girl with loose anagen hair syndrome, highlighting the importance of recognizing the condition early to avoid misdiagnosis and unnecessary treatments, and noting her spontaneous improvement with conservative management.
July 2025 in “Clinical Cosmetic and Investigational Dermatology” This study found that platelet-rich plasma therapy significantly improved hair density and reduced hair shedding in Vietnamese patients with androgenetic alopecia, with high patient satisfaction and minimal side effects.
January 2025 in “International Journal of Trichology” This report describes a rare case of loose anagen hair syndrome in a young Indian child, highlighting its clinical and trichoscopic features.
January 2023 in “Research Square (Research Square)” This study found that patients with COVID-19 infection lasting longer than two weeks experienced more severe post-infection hair loss, with women and older individuals particularly affected.
September 2022 in “Health and Medical Journal” This case report describes a 19-year-old woman with systemic lupus erythematosus and telogen effluvium, who experienced new hair growth and increased hair density after 90 days of treatment with 2% topical minoxidil and oral keratin-based antioxidants.
January 2021 in “Journal of Pakistan Association of Dermatology” This article presents cases of two patients experiencing excessive hair shedding 2 to 3 months after COVID-19 infection, highlighting a possible link to telogen effluvium.
January 2021 in “International journal of dermatology, venereology and leprosy sciences” This study found that, among 100 patients with alopecia areata, the most prevalent subtype was patchy alopecia areata, with characteristic trichoscopic features including black dots, yellow dots, and empty hair follicles.
September 2016 in “Más dermatología” Postpartum hair loss usually stops within 4-6 months.
March 2004 in “Journal of The American Academy of Dermatology” This study found that patients with systemic lupus erythematosus and diffuse hair loss showed non-scarring alopecia without inflammation and a decrease in total hair follicles.
March 2004 in “Journal of The American Academy of Dermatology” This report describes a unique case of dyschromatosis universalis in a 10-year-old Haitian male, notable for the presence of a silvery sheen to his scalp hairs and eyelashes, which may represent a variation of the condition.
January 2012 in “Guangdong Medical Journal” This study found that androgenic alopecia often begins at a young age and may be more severe with a family history, though treatment efficacy did not depend on family history.
November 2021 in “International Journal of Research in Dermatology” This study found that lower hemoglobin and serum ferritin levels were significantly associated with male pattern hair loss in patients diagnosed with non-cicatricial alopecia.